Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-12-001308

CEO gave up 21,475 shares (to pay taxes)

  • CEO acquired 102,781 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEWIS JONATHAN CEO 2011-12-30 Grant or award +102,781 581,991 D
LEWIS JONATHAN CEO 2011-12-31 Shares withheld for taxes −21,475 $4.41 $94,705 560,516 D
Loading xslF345X03/doc4.xml…